Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xbiotech Inc (XBIT)

Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 74,086
  • Shares Outstanding, K 30,488
  • Annual Sales, $ 0 K
  • Annual Income, $ -38,530 K
  • EBIT $ -35 M
  • EBITDA $ -33 M
  • 60-Month Beta 0.78
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.45

Options Overview Details

View History
  • Implied Volatility 291.06% (-357.20%)
  • Historical Volatility 93.51%
  • IV Percentile 33%
  • IV Rank 35.49%
  • IV High 710.96% on 11/07/25
  • IV Low 60.09% on 12/02/25
  • Expected Move (DTE 28) 0.50 (19.82%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 40
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 322
  • Open Int (30-Day) 290
  • Expected Range 2.03 to 3.03

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.15 +17.67%
on 11/19/25
2.68 -5.60%
on 12/05/25
+0.18 (+7.66%)
since 11/18/25
3-Month
2.09 +21.05%
on 11/05/25
3.44 -26.45%
on 11/11/25
-0.23 (-8.33%)
since 09/18/25
52-Week
2.09 +21.05%
on 11/05/25
6.66 -61.99%
on 12/20/24
-3.56 (-58.46%)
since 12/18/24

Most Recent Stories

More News
XBiotech: Q3 Earnings Snapshot

XBiotech: Q3 Earnings Snapshot

XBIT : 2.53 (+4.12%)
XBiotech Signs New Executive Agreement with CEO

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

XBIT : 2.53 (+4.12%)
XBiotech: Q2 Earnings Snapshot

XBiotech: Q2 Earnings Snapshot

XBIT : 2.53 (+4.12%)
XBiotech: Q1 Earnings Snapshot

XBiotech: Q1 Earnings Snapshot

XBIT : 2.53 (+4.12%)
XBiotech Pauses Rheumatology program

XBIT : 2.53 (+4.12%)
XBiotech: Q3 Earnings Snapshot

XBiotech: Q3 Earnings Snapshot

XBIT : 2.53 (+4.12%)
Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives

The urgent need for innovative technologies to accelerate the development of life-saving %Cancer therapies has never been more critical. With millions of lives and billions of dollars at stake, the potential...

MRK : 100.69 (+1.52%)
NVS : 135.27 (+0.18%)
RHHBY : 50.2700 (+1.35%)
AZN : 90.61 (+0.83%)
BMRN : 51.95 (+0.29%)
KTRA : 0.2154 (-6.31%)
XBIT : 2.53 (+4.12%)
RKV.VN : 0.100 (unch)
XBiotech: Q2 Earnings Snapshot

XBiotech: Q2 Earnings Snapshot

XBIT : 2.53 (+4.12%)
XBiotech: Q1 Earnings Snapshot

XBiotech: Q1 Earnings Snapshot

XBIT : 2.53 (+4.12%)
XBiotech Announces Successful Completion of Phase I portion of Pancreatic Cancer Study

Novel Natrunix Treatment Shows Promise in Combination Chemotherapy for Treatment of Pancreatic Cancer...

XBIT : 2.53 (+4.12%)

Business Summary

XBiotech Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing True Human(TM) monoclonal antibodies for treating diseases. XBiotech Inc. is based in AUSTIN, United States.

See More

Key Turning Points

3rd Resistance Point 2.74
2nd Resistance Point 2.64
1st Resistance Point 2.59
Last Price 2.53
1st Support Level 2.44
2nd Support Level 2.34
3rd Support Level 2.29

See More

52-Week High 6.66
Fibonacci 61.8% 4.91
Fibonacci 50% 4.37
Fibonacci 38.2% 3.83
Last Price 2.53
52-Week Low 2.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar